MediMergent: The Real-World Evidence Company
Our Business
Provides a digital platform that collects, integrates and analyzes Real-World Data (RWD) related to performance, outcomes and value.
Why?
Without RWD, Especially The Voice Of The Patient, Stakeholders Are Working Blind
- For key stakeholders throughout the healthcare supply chain, integrated and validated RWD, linking performance to outcomes, is critical to value-based contracting.
- RWE impacts usage, costs, benefits and risks of medical products and services and is predicated on valid RWD.
MediMergent Collaborates with FDA On Real-World Evidence
Under a Research Collaboration Agreement with the U.S. Food and Drug Administration, MediMergent designed and currently deploys it’s proprietary platform to collect RWD and validate rules-based analytic processes. The collaboration focuses on: traditional and non-traditional data sources including wearable devices and digital apps; processes to standardize, correlate and integrate structured and unstructured data; and algorithms to bring transparency to siloed data.